[1] 陈书尚,石良冲,朱凌峰等.三种手术方式治疗大体积前列腺增生症的疗效比较[J].医学临床研究,2013,30(3):433-436. [2] 杨鲲,陈向东,高进等.前列腺外科包膜的病理组成研究及其临床意义探讨[J].医学临床研究,2011,28(5):807-809. [3] 陈向东,王忠,齐隽等. 经尿道前列腺剜除术中对前列腺包膜和外科包膜性状的观察[J?.中国男科学杂志, 2009,23(5):43-45. [4] Rick, F.G.,Abi-Chaker, A.,Szalontay, L. et al.Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist[J].Proceedings of the National Academy of Sciences of the United States of America,2013,110(7):2617-2622. [5] Wang,X.,Lin,W.-J.,Izumi,K. et al.Increased infiltrated macrophages in benign prostatic hyperplasia (BPH): Role of stromal androgen receptor in macrophage-induced prostate stromal cell proliferation[J].The Journal of Biological Chemistry,2012,287(22):18376-18385. [6] Barve, I.J.,Chen, L.-H.,Wei, P.C.P. et al.Enantioselective synthesis of (-)-(R) Silodosin by ultrasound-assisted diastereomeric crystallization[J].Tetrahedron,2013,69(13):2834-2843. [7] Xiao Gu,Kurt Strom,Massimiliano Spaliviero et al.Does prostate configuration affect the efficacy and safety of GreenLight HPS? laser photoselective vaporization prostatectomy (PVP)?[J].Lasers in medical science,2013,28(2):473-478. [8] Parsons,J.K.,Sarma,A.V.,McVary,K. et al.Obesity and benign prostatic hyperplasia: Clinical connections, emerging etiological paradigms and future directions[J].The Journal of Urology,2013,189(1S):S102-S106. [9] Kahokehr,A.,Vather,R.,Nixon,A. et al.Non-steroidal anti-inflammatory drugs for lower urinary tract symptoms in benign prostatic hyperplasia: Systematic review and meta-analysis of randomized controlled trials[J].BJU international,2013,111(2):304-311. [10] 陈斌,郑嘉欣,张开颜等.经尿道前列腺剜除术与电切术治疗不同质量良性前列腺增生的前瞻性研究[J].中华泌尿外科杂志,2013,34(8):608-612. [11] 王朝,盛玉文,刘奔等.经尿道前列腺等离子腔内剜除术治疗大体积良性前列腺增生的临床疗效[J].北京医学,2014,36(2):102-105. [12] Gravas,S.,DeLaRosette,J.J..Investigational therapies targeted to the treatment of benign prostatic hyperplasia[J].Expert opinion on investigational drugs,2013,22(3):357-368.
|